FDI and Merger Control in Germany (2026): How to Navigate Dual Screening for Cross‑border M&A

FDI and merger control Germany has become the defining regulatory hurdle for cross‑border acquisitions in 2026, as national‑security screening continues to widen in scope while merger control enforcement remains as rigorous as ever. Buyers acquiring German targets now routinely face two parallel clearance processes, investment control under the foreign trade regime and antitrust review before the Bundeskartellamt or the European Commission, each with distinct triggers, timelines and outcomes. Getting the coordination wrong can add months of delay, jeopardise closing certainty and expose the parties to prohibition or costly remedies. This practitioner guide explains how the two regimes fit together, when each is triggered, how to sequence filings, and how to allocate the resulting risk in the sale and purchase agreement.

Who should read this and what you will get: This guide is written for in‑house counsel, corporate development and M&A teams, and external advisers who must decide filing strategy and deal structure for acquisitions into Germany. You will find a comparison of the two regimes, a decision framework for identifying triggers, sequencing options for parallel and sequential filings, a granular coordination checklist across the deal lifecycle, sample SPA drafting concepts, and a set of FAQs covering the most common questions on dual screening.

FDI and Merger Control Germany: Scope, Authorities and Outcomes

Understanding fdi and merger control Germany starts with recognising that these are two separate legal regimes pursuing different public objectives. Merger control protects effective competition; investment control protects national security and public order. A single transaction can fall under both, one, or neither, and the two assessments proceed on wholly distinct legal tests. Treating them as a single “regulatory approval” is the most common strategic error in cross‑border deals.

Legal bases and authorities

German merger control is grounded in the Act against Restraints of Competition (Gesetz gegen Wettbewerbsbeschränkungen, GWB), enforced by the Bundeskartellamt, the German Federal Cartel Office. Where a concentration meets EU‑level thresholds, jurisdiction shifts to the European Commission under the EU Merger Regulation (Council Regulation (EC) No 139/2004), operating under the “one‑stop shop” principle that a single Commission review generally replaces national filings.

German foreign direct investment screening operates under a different statutory foundation: the Foreign Trade and Payments Act (Außenwirtschaftsgesetz, AWG) and its implementing ordinance, the Foreign Trade and Payments Ordinance (Außenwirtschaftsverordnung, AWV). The competent authority is the Federal Ministry for Economic Affairs and Climate Action (Bundesministerium für Wirtschaft und Klimaschutz, BMWK), which conducts national‑security review of qualifying acquisitions by non‑EU and, in sensitive cases, non‑EFTA investors. The AWG and AWV texts are published on the Federal Ministry of Justice’s official portal, Gesetze im Internet. Germany’s regime also operates within the framework of the EU FDI Screening Regulation, which provides for cooperation between Member States and the European Commission on inward investment.

Typical outcomes under each regime

Both regimes can end in clearance, conditional clearance, or prohibition, but the substance of any conditions differs sharply. In merger control, remedies address competitive harm and are typically structural (divestiture of a business or asset) or behavioural (access commitments, firewalls). In investment control, mitigations address security concerns and may include restrictions on access to sensitive technology, limits on ownership rights, board observer arrangements, security agreements, or undertakings on the location of critical functions.

Overlap and conflicts between the regimes

Because the two authorities pursue different objectives, their conclusions are independent. A transaction can be cleared as competitively benign yet raise acute national‑security concerns, or vice versa. Where both regimes apply, the deal cannot close until both have concluded. The practical consequence is that the slower or more uncertain process governs the overall timetable, and remedies negotiated in one forum will not satisfy the other. Coordinating fdi and merger control Germany filings therefore means managing two parallel workstreams rather than a single approval pathway.

Image alt text: Flowchart comparing parallel FDI and merger control Germany filing timelines in 2026.

When Does an Acquisition Trigger FDI Screening in Germany?

The first analytical step in any inbound deal is to determine whether German investment control is engaged at all. Unlike merger control, which turns primarily on turnover, FDI screening turns on a combination of the investor’s origin, the size of the acquired stake, and the sensitivity of the target’s activities.

Statutory triggers and scope

Foreign direct investment screening in Germany applies where a foreign investor acquires voting rights in a German company above defined thresholds. The AWG and AWV distinguish between a cross‑sectoral regime, which applies broadly to acquisitions by non‑EU/non‑EFTA investors of sensitive targets, and a sector‑specific regime, which applies to defence and certain security‑critical goods regardless of the investor’s origin. In sensitive sectors, comparatively low acquisition thresholds can bring a transaction within scope, and a mandatory notification obligation may arise. The applicable thresholds are those set out in the AWV as currently in force. Where a mandatory filing is required, closing before clearance is prohibited and the transaction is provisionally ineffective until the review concludes.

Sectoral focus and national security indicators

National security screening in Germany concentrates on activities where foreign control could affect public order or defence capability. Sensitive fields include critical infrastructure (such as energy, water, telecommunications, health, transport and finance), defence and military technology, dual‑use goods, and a broad category of advanced technologies such as artificial intelligence, robotics, semiconductors, cybersecurity, and sensitive personal or health data. The AWV sets out a list of case groups that attract heightened scrutiny, and the BMWK publishes practical guidance; advisers should map the target’s activities against these categories at the earliest stage.

Practical red flags for deals

• Investor origin. Acquisitions by non‑EU/non‑EFTA investors carry materially higher screening risk, and state‑linked or state‑owned acquirers attract particular attention.
• Sensitive target activities. Any involvement in critical infrastructure, defence, dual‑use technology or listed emerging technologies should be treated as a presumptive trigger.
• Access to sensitive data or IP. Targets holding sensitive personal data, health records, or security‑relevant intellectual property warrant careful review.
• Indirect acquisitions. Screening can be triggered by upstream changes of control even where the direct acquirer is EU‑based.

Where any of these red flags are present, the prudent course is to engage counsel to scope both fdi and merger control Germany exposure before signing, so that the filing strategy is baked into the deal timetable rather than discovered afterwards.

How FDI Screening Affects Timing and Process for Merger Control Clearance

The interaction of investment control with merger control is where most deal risk crystallises. Because the two regimes run on separate clocks and neither defers to the other, sequencing decisions directly determine the critical path to closing.

The parallel filing model

In most transactions where both regimes apply, the parties file with the Bundeskartellamt (or the European Commission) and with the BMWK in parallel. The advantage is obvious: the two reviews run concurrently, and the overall timetable is driven by whichever process takes longer rather than by their sum. Parallel filing requires disciplined project management, harmonised factual narratives, coordinated responses to information requests, and a shared calendar so that the deal team can anticipate the binding milestones on each track.

Sequential filing risks

Occasionally parties consider filing sequentially, for example, securing merger clearance first and only then commencing investment control review. This approach almost always lengthens the overall timetable and rarely reduces risk. It can, however, be unavoidable where the investment control analysis depends on information that only emerges during merger review, or where a mandatory FDI notification must be lodged promptly after signing. In practice, coordinating FDI and antitrust filings in parallel is the default strategy for time‑sensitive deals.

Timelines and standstill periods

Merger control imposes a suspensory obligation: a notifiable concentration may not be implemented before clearance. Investment control imposes its own standstill where a mandatory notification applies, and even in voluntary cases the parties will typically wait for confirmation of no objection before closing. The combined effect is that closing is conditional on both green lights. The Bundeskartellamt operates statutory Phase I and Phase II review periods under the GWB, and the European Commission applies its own statutory timetable under the EUMR; the BMWK review comprises an initial screening period that may be extended into an in‑depth phase where concerns arise, with the applicable periods set out in the AWG/AWV. Review clocks can be suspended where the authority requests further information.

Managing confidentiality and information requests

Investment control review can involve security‑sensitive material and, in some cases, restricted handling, a dimension absent from ordinary merger filings. Parties must therefore manage two distinct confidentiality regimes and ensure that information provided to one authority is consistent with, but appropriately segregated from, information provided to the other. Inconsistent factual accounts across the two filings are a common and avoidable source of delay.

Practical Coordination Checklist, Pre‑Signing, Signing, Pre‑Closing, Post‑Closing

Effective coordination of fdi and merger control Germany depends on treating regulatory strategy as a project that begins during due diligence and runs through to post‑closing compliance. The checklist below breaks the workstream into four phases.

Phase 1, Pre‑signing: due diligence and risk allocation

• Regulatory mapping. Assess both merger control and FDI exposure early: analyse turnover figures against merger thresholds and map target activities against sensitive sectors under the AWG/AWV.
• Investor profiling. Confirm the acquirer’s ultimate ownership, EU/EFTA status and any state links, which drive the FDI risk assessment.
• Jurisdiction check. Determine whether merger control sits with the Bundeskartellamt or the European Commission, and whether additional foreign filings are required for a multi‑jurisdictional deal.
• Risk allocation. Agree in principle which party bears regulatory risk and reflect it in the term sheet before drafting the SPA.

Phase 2, Signing to filing: notification strategy

• Sequencing decision. Confirm parallel versus sequential filing and lock a shared regulatory calendar with binding milestones for each authority.
• Pre‑notification engagement. Where appropriate, arrange informal contact with the Bundeskartellamt and the BMWK to test the analysis and calibrate the filing packages.
• Harmonised information packs. Prepare consistent factual narratives across the merger and FDI filings, tailored to each authority’s focus.
• Filing responsibility. Confirm who lodges each filing. In merger control the acquirer typically notifies; in investment control the acquirer generally bears the notification obligation, with seller cooperation obligations built into the SPA.

Phase 3, Pre‑closing: monitoring and interim measures

• Standstill compliance. Ensure no gun‑jumping: the parties must not implement the concentration or complete the acquisition before both clearances.
• Information request management. Track and respond to each authority’s requests promptly; delayed responses can stop the clock and extend the timetable.
• Remedy readiness. Prepare fallback positions, divestiture candidates for merger control and mitigation concepts for investment control, before concerns escalate.
• Interim conduct. Observe permitted pre‑closing conduct restrictions and keep the two authorities aligned on any interim arrangements.

Phase 4, Post‑closing: reporting and compliance

• Condition compliance. Implement any remedies or mitigations on the agreed timetable and document delivery.
• Ongoing obligations. Track continuing undertakings such as behavioural commitments, security agreements, or reporting duties owed to the BMWK.
• Integration controls. Sequence integration so that it does not breach conditions attached to either clearance.
• Record retention. Maintain a complete file of filings, correspondence and clearance decisions for future transactions and audits.

A disciplined checklist of this kind is the single most effective tool for reducing closing risk when coordinating FDI and antitrust filings, because it converts an unpredictable regulatory process into a managed timetable.

Risk Allocation and Deal Drafting, SPA Clauses, Conditions Precedent and Remedies

The commercial risk created by dual screening must be allocated in the sale and purchase agreement. Well‑drafted provisions do not remove regulatory risk, but they determine who carries it and what happens if clearance is delayed, conditioned or refused. The concepts below are illustrative examples of drafting approaches, not legal advice, and should be tailored to the specific transaction.

Conditions precedent versus warranties

Both merger control clearance and, where applicable, FDI clearance should be expressed as conditions precedent to closing. Draft each as a separate condition, because the two can be satisfied at different times and on different terms. Distinguish clearly between a condition that requires unconditional clearance and one satisfied by clearance subject to acceptable conditions, and define what counts as “acceptable”, for instance, remedies that do not materially diminish the value of the target.

Remedies and divestiture clauses

• Efforts standard. Specify the level of effort the buyer must expend to obtain clearance, for example, an obligation to accept mitigations up to a defined materiality cap, or a broader “hell‑or‑high‑water” commitment.
• Divestiture obligations. Where structural remedies are foreseeable, define which assets may be offered and set limits protecting the buyer’s core rationale.
• Mitigation obligations. For investment control, address the buyer’s willingness to accept security‑related undertakings such as access restrictions, board observer rights or security agreements.

Indemnities, break fees and escrow structure

A reverse break fee compensates the seller if the deal fails on regulatory grounds attributable to the buyer. Specific indemnities can address defined regulatory outcomes, and an escrow can secure the delivery of post‑closing remedies or mitigation obligations. Long‑stop date drafting is critical: allow enough time for two parallel reviews, including potential in‑depth phases, and provide for extension or termination if either clearance is outstanding at the deadline.

Notifications and Filing Strategy, Step‑by‑Step Timelines and a Sample Parallel Plan

Translating strategy into an executable filing plan is the operational heart of fdi and merger control Germany. The parties must prepare tailored packages for each authority and align their submission dates against a realistic calendar.

Filing package checklist

• Merger control filing. Details of the parties, transaction structure, turnover figures, affected markets, market shares and competitive assessment for the Bundeskartellamt, or a Form CO for the European Commission.
• FDI notification. Description of the acquirer and its ownership, the target’s activities, the shareholding acquired, and the security‑relevant context for the BMWK.
• Supporting evidence. Corporate structure charts, financial data, and any technology or infrastructure descriptions relevant to national‑security review.

Practical timing scenarios

• Small domestic deal. If turnover thresholds are not met and the target is not sensitive, neither regime applies and no filing is required, but the analysis should still be documented.
• Strategic asset acquisition. A deal meeting merger thresholds and involving a sensitive target requires parallel Bundeskartellamt and BMWK filings, with the timetable driven by the longer review.
• Defence or security technology. Sector‑specific FDI review can apply regardless of investor origin and may extend into an in‑depth phase; this is typically the critical path and should shape the long‑stop date.

Practical tips for regulator meetings

Pre‑notification engagement with both authorities is valuable. It allows the parties to test their theory of the case, identify likely concerns early, and calibrate the volume of information required. Approach each authority with a consistent factual foundation, and prepare senior decision‑makers to articulate the strategic rationale for the transaction and, where relevant, its security implications.

Case Study Summaries and Lessons

The following anonymised illustrations reflect recurring patterns in cross‑border M&A into Germany and the lessons they offer for coordinating dual screening.

• The technology target cleared on competition but conditioned on security. A non‑EU acquirer of a German software company obtained straightforward merger clearance because the parties barely overlapped, yet the BMWK required mitigations on access to sensitive source code and customer data. Lesson: merger clearance says nothing about the FDI outcome; scope security exposure independently.
• The infrastructure deal delayed by sequential filing. Parties who waited for merger clearance before commencing FDI review saw closing slip by months when the BMWK opened an in‑depth phase. Lesson: file in parallel wherever possible to keep the two clocks running concurrently.
• The deal saved by a well‑drafted SPA. A reverse break fee and a clearly defined efforts standard gave both sides certainty when the buyer had to accept behavioural mitigations, avoiding a dispute over whether the buyer had done enough. Lesson: allocate regulatory risk precisely in the agreement before signing.

Next Steps, Deciding on Counsel and Getting Expert Help

Because fdi and merger control Germany involves two authorities, two legal tests and two timetables, transactions with any German nexus benefit from early, integrated advice combining antitrust and investment control expertise. Retain counsel before signing so that regulatory strategy shapes the deal structure and the SPA rather than the reverse. Ask prospective advisers how they coordinate parallel filings, how they engage with the Bundeskartellamt and the BMWK, and how they draft conditions precedent and remedies. For related guidance, see the Competition Lawyer Germany, When To Hire guide, the Germany, Competition practice hub, and supporting resources on the FDI notification process and merger control filing.

Conclusion

Navigating fdi and merger control Germany in 2026 is fundamentally an exercise in coordination: two regimes, two authorities and two timetables that must be managed as a single deal project without conflating their distinct tests. The decisive moves happen early, scoping both regimes during due diligence, choosing a parallel filing strategy, engaging the Bundeskartellamt and the BMWK before formal notification, and allocating regulatory risk precisely in the SPA. Parties who treat dual screening as an afterthought risk delay, remedies and failed closings; those who plan for it convert an unpredictable process into a managed timetable.

With disciplined sequencing and well‑drafted deal documents, cross‑border acquirers can meet both the competition and national‑security requirements of fdi and merger control Germany while protecting deal certainty.

This article is for informational purposes only and does not constitute legal advice. It addresses German and EU law as at the date of review; specific transactions should be assessed with qualified counsel, and current statutory thresholds and timelines should be verified against the AWG, AWV, GWB and EUMR as in force.

Sources

1. Bundeskartellamt (German Federal Cartel Office)
2. European Commission, Competition (Mergers)
3. EUR‑Lex, Council Regulation (EC) No 139/2004 (EUMR)
4. Gesetze im Internet (Federal Ministry of Justice), AWG / AWV / GWB
5. Bundesministerium für Wirtschaft und Klimaschutz (BMWK)